APA citiranje

Gadd, A. J., Castelletto, V., Kabova, E., Shankland, K., Perrie, Y., Hamley, I., . . . Edwards, A. D. (2018). High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation. Eur J Pharm Sci.

Citação norma Chicago

Gadd, Adam J.R., Valeria Castelletto, Elena Kabova, Kenneth Shankland, Yvonne Perrie, Ian Hamley, Alexander J.A Cobb, F. Greco, and Alexander D. Edwards. "High Potency of Lipid Conjugated TLR7 Agonist Requires Nanoparticulate or Liposomal Formulation." Eur J Pharm Sci 2018.

MLA citiranje

Gadd, Adam J.R., et al. "High Potency of Lipid Conjugated TLR7 Agonist Requires Nanoparticulate or Liposomal Formulation." Eur J Pharm Sci 2018.